http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30231713

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Review
endingPage 142
issn 0954-0261
1369-1627
issueIdentifier 2
pageRange 134-142
publicationName International review of psychiatry (Abingdon, England)
startingPage 134
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b2a768fa40a658a468dbe60858f3b30b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c52daf6ac6c7d714e6a1dab5c6fe103a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_88e3b9eb2560cd0b2b1701631f536bdb
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_eb06955ce20c0d1ef251b9919a3a4b4c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f1cb47e07c756b60cae1e94f3a77e0e7
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9c16b5f571479e7f54206728b800ec6f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_db2969b5439acef3c66f6012d798cd7d
bibliographicCitation Beardsley PM, Thomas BF, Mcmahon LR. Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. International Review of Psychiatry. 2009 Jan;21(2):134–42. doi: 10.1080/09540260902782786.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82858d2e6cb1bcd0bc76aa54b562ff88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec50888c466e76877d06dcbc7b97a21f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4de567bc7978511aec943dbb581f37c6
date 200901
identifier https://doi.org/10.1080/09540260902782786
https://pubmed.ncbi.nlm.nih.gov/19367507
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/25844
https://portal.issn.org/resource/ISSN/1369-1627
https://portal.issn.org/resource/ISSN/0954-0261
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders
discusses http://id.nlm.nih.gov/mesh/M0235470
http://id.nlm.nih.gov/mesh/M0006756
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0016885
http://id.nlm.nih.gov/mesh/M0155202
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D043884Q000037
http://id.nlm.nih.gov/mesh/D010880Q000494
http://id.nlm.nih.gov/mesh/D012201
http://id.nlm.nih.gov/mesh/D019966Q000188
http://id.nlm.nih.gov/mesh/D011720Q000494
http://id.nlm.nih.gov/mesh/D004298Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009434Q000187
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D001921Q000187
http://id.nlm.nih.gov/mesh/D001921Q000473
http://id.nlm.nih.gov/mesh/D001921Q000378
http://id.nlm.nih.gov/mesh/D009434Q000473
http://id.nlm.nih.gov/mesh/D009434Q000378
http://id.nlm.nih.gov/mesh/D019966Q000473
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000077285
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b278f6fa681694fa5d22a196adf47fef
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104850
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281515
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4970cb79f2ab18fd438382784581e8af
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128348432

Total number of triples: 59.